IRIS
MATUCCI CERINIC, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.547
NA - Nord America 11.333
EU - Europa 10.782
SA - Sud America 2.148
Continente sconosciuto - Info sul continente non disponibili 1.053
AF - Africa 187
OC - Oceania 24
Totale 38.074
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.798
RU - Federazione Russa 6.304
SG - Singapore 5.310
CN - Cina 3.592
BR - Brasile 1.795
IT - Italia 1.681
HK - Hong Kong 1.603
VN - Vietnam 880
FR - Francia 714
RO - Romania 709
BD - Bangladesh 402
DE - Germania 340
CA - Canada 261
GB - Regno Unito 230
NL - Olanda 182
IN - India 164
MX - Messico 131
SE - Svezia 127
AR - Argentina 121
FI - Finlandia 89
AT - Austria 88
PL - Polonia 82
TR - Turchia 81
JP - Giappone 64
EC - Ecuador 61
ES - Italia 59
ID - Indonesia 58
IQ - Iraq 57
ZA - Sudafrica 53
CO - Colombia 42
MY - Malesia 42
VE - Venezuela 38
MA - Marocco 35
UZ - Uzbekistan 35
UA - Ucraina 34
JM - Giamaica 33
CR - Costa Rica 26
PK - Pakistan 26
LT - Lituania 25
PY - Paraguay 25
AE - Emirati Arabi Uniti 24
CL - Cile 24
NP - Nepal 24
SA - Arabia Saudita 24
TN - Tunisia 22
PH - Filippine 21
EG - Egitto 20
CH - Svizzera 18
AU - Australia 16
IL - Israele 16
PE - Perù 16
UY - Uruguay 16
JO - Giordania 15
TH - Thailandia 15
TT - Trinidad e Tobago 14
TW - Taiwan 14
DZ - Algeria 13
PT - Portogallo 13
NI - Nicaragua 12
SN - Senegal 12
KE - Kenya 11
DO - Repubblica Dominicana 10
HN - Honduras 10
GT - Guatemala 9
AL - Albania 8
AZ - Azerbaigian 8
BE - Belgio 8
BH - Bahrain 8
MD - Moldavia 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
GR - Grecia 7
HU - Ungheria 7
KR - Corea 7
KZ - Kazakistan 7
LV - Lettonia 7
OM - Oman 7
BO - Bolivia 6
CY - Cipro 6
ET - Etiopia 6
IR - Iran 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
RS - Serbia 6
BB - Barbados 5
LU - Lussemburgo 5
PA - Panama 5
SV - El Salvador 5
AM - Armenia 4
AO - Angola 4
IE - Irlanda 4
QA - Qatar 4
BN - Brunei Darussalam 3
BS - Bahamas 3
BY - Bielorussia 3
DK - Danimarca 3
GY - Guiana 3
KG - Kirghizistan 3
BW - Botswana 2
GP - Guadalupe 2
Totale 36.982
Salva come PNG Salva come JPEG
Città #
Dallas 2.962
Singapore 2.595
San Jose 1.688
Hong Kong 1.586
Moscow 1.440
Ashburn 1.280
Council Bluffs 695
Hefei 629
Shanghai 624
Lauterbourg 547
Beijing 400
Ho Chi Minh City 319
New York 258
Santa Clara 240
Milan 223
Los Angeles 209
Hanoi 193
Rome 163
São Paulo 155
Nuremberg 109
Atlanta 89
Rio de Janeiro 75
Brooklyn 74
Munich 74
Orem 71
Montreal 69
Chicago 68
Warsaw 64
Guangzhou 61
Denver 59
Boardman 58
Florence 57
Mexico City 55
Amsterdam 53
Omaha 52
Tokyo 51
Naples 50
Stockholm 50
Chennai 47
San Francisco 47
Da Nang 46
Phoenix 46
Toronto 46
Bologna 45
London 45
Buffalo 44
Boston 40
Brasília 37
Houston 37
Frankfurt am Main 36
Johannesburg 35
Vienna 33
Assago 32
Belo Horizonte 32
Lappeenranta 32
Turin 32
Helsinki 31
Hangzhou 30
Shenzhen 30
Washington 30
Palermo 29
Tashkent 29
Tianjin 28
Haiphong 27
Guayaquil 25
St Louis 25
The Dalles 24
Turku 24
Charlotte 23
Dhaka 23
Manchester 23
North Bergen 23
Philadelphia 23
Porto Alegre 22
Baghdad 21
Bari 21
Istanbul 21
Kuala Lumpur 21
Poplar 21
San José 21
Seattle 21
Las Vegas 20
Mumbai 20
Clifton 19
Curitiba 19
Hải Dương 19
Paris 19
Secaucus 19
Ankara 18
Salvador 18
Lawrence 17
New Delhi 17
Princeton 17
Quito 17
Santo André 17
Vancouver 17
Cagliari 16
Campinas 16
Goiânia 16
Biên Hòa 15
Totale 19.109
Salva come PNG Salva come JPEG
Nome #
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 1.052
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 571
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 511
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 464
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: A EUSTAR database analysis 407
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database 400
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 395
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 350
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 259
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 235
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 167
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 160
The Italian version of the Hand Mobility in Scleroderma (HAMIS) test: evidence for its validity and reliability 157
"Atlas of Capilaroscopy in Rheumatic Diseases" - Chapter: The microcirculation and Rheumatic Diseases 147
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review 141
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 137
Systemic amyloidosis: a challenge for the rheumatologist 136
"Autoimmunity" - Chapter: Autoantibodies in systemic sclerosis 130
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 124
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 123
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 122
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 120
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 120
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative 119
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 116
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 114
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 113
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 113
Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation 113
A custom-made splint is useful in the treatment of Osteoarthritis of the trapeziometacarpal joint 112
Very early and early diagnosis of systemic sclerosis 111
A comparison of two podiatric protocols for metatarsalgia in patients with rheumatoid arthritis and osteoarthritis 111
Managing complicated digital ulcers 110
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 110
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 107
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 106
The COVID-19 pandemic highlights the need for a psychological support in systemic sclerosis patients 105
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis 104
A contribution to the debate about the possible different clinical severity between hemophilia A and B 104
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 103
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 103
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs] 103
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 102
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 102
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 101
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 100
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity 99
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative 99
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis 98
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 97
Historical perspective of scleroderma 97
"Epigenetic in rheumatic diseases" - Chapter: Epigenetics in systemic sclerosis 97
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 96
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases 96
A combined rehabilitative program is efficacious in the treatment of hands of Systemic Sclerosis patients 94
A genetic variant located in the promoter of the uPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 93
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 93
[Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis] 93
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 93
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 93
Infection-Associated Flares in Systemic Lupus Erythematosus 92
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 92
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 92
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art! 92
Editorial: Cardiovascular involvement in autoimmune diseases, volume II 92
Stressful life events at the onset and during the evolution of systemic sclerosis 91
Riabilitazione dell’articolazione temporomandibolare (atm) in pazienti con sclerosi sistemica (ssc): confronto tra due protocolli. Risultati preliminari 89
A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia 89
Alfabetizzazione sanitaria e pazienti affetti da Sclerosi Sistemica 89
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 88
Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study 87
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 85
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 85
Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down 85
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 85
Integrative Transcriptomic Analysis of Peripheral Blood Monocytes in Systemic Sclerosis and Shared Pathogenic Pathways in Autoimmune Diseases 84
Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: A preliminary report 83
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 83
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells 82
Hand Function in Scleroderma 82
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 82
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis 82
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 82
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 82
The combination of connective tissue massage, Kabat's technique, kinesitherapy and home exercise is helpful in face rehabilitation of Systemic Sclerosis patients 81
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition 81
Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight 80
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study 80
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 80
The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort 79
Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review 79
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 78
EULAR recommendations for the treatment of systemic sclerosis: 2023 update 78
Shoulder impingement syndrome in water polo players: muscle shortening manoeuvre controls pain intensity, recovers function and normalizes sonographic parameters 77
A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review 77
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine 77
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 76
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database 76
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 75
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 75
Totale 13.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 0 11 3 1 3 1 0 0 16 1 2
2022/2023170 42 28 9 1 3 16 29 20 15 0 6 1
2023/20241.249 4 9 14 20 18 574 222 176 10 26 48 128
2024/20258.238 986 202 92 159 357 567 1.513 542 1.358 1.183 612 667
2025/202626.348 1.984 2.651 2.404 2.679 1.577 670 3.092 1.584 5.682 1.366 998 1.661
2026/20272.026 806 1.220 0 0 0 0 0 0 0 0 0 0
Totale 38.074